PB2708: SYMPTOM BURDEN AND ITS IMPACT ON DAILY LIFE IN PATIENTS WITH IDIOPATHIC MULTICENTRIC CASTLEMAN’S DISEASE (IMCD): AN EXPLORATORY ANALYSIS OF THE SURVEY’S INTERNAL CONSTRUCT VALIDITY

• Matt Franklin,
• Francis Shupo,
• Emily Jones,
• Nicola Mason,
• Grace Wayi-Wayi,
• Karan Kanhai,
• Natasa Zibelnick,
• Mileva Repasky,
• Kelly Makarounas-Kirchmann,
• Sudipto Mukherjee,
• John Brazier

Affiliations

Matt Franklin

1 School of Health and Related Research, sheffield, United Kingdom

Francis Shupo

2 EUSA Pharma UK Ltd, Hemel Hempstead, United Kingdom

Emily Jones

3 Lumanity, London, United Kingdom

Nicola Mason

3 Lumanity, London, United Kingdom

Grace Wayi-Wayi

2 EUSA Pharma UK Ltd, Hemel Hempstead, United Kingdom

Karan Kanhai

2 EUSA Pharma UK Ltd, Hemel Hempstead, United Kingdom

Natasa Zibelnick

2 EUSA Pharma UK Ltd, Hemel Hempstead, United Kingdom

Mileva Repasky

4 Castleman disease collaborative network, Paso Robles, United States

Kelly Makarounas-Kirchmann

5 Monash University, School of Public Health, Melbourne, Australia

Sudipto Mukherjee

6 Cleveland Clinic Main Campus, Cleveland, United States

John Brazier

1 School of Health and Related Research, sheffield, United Kingdom